BSE filing, NSE: AGARWALEYE. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹511.70
- Market cap
- ₹16,222 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 109.3×Sector 54.5×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Dr. Agarwals Health Care Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%). H1 FY27 revenue ₹1,269 Cr (+28.7%), PAT ₹112 Cr (+50.1%). Strategy is aggressive facility expansion, with 65 FY27E additions.
Dr. Agarwals Health Care Financial Results
Dr. Agarwal's H1 FY27 revenue rose 28.7% to Rs 1,269 crore; PAT rose 50.1% to Rs 112 crore. Amar Agarwal's executive chairman appointment awaits postal ballot approval.
Dr. Agarwals Health Care Board Meeting Date
Dr. Agarwal's Health Care schedules a board meeting on November 5, 2026 to consider Q2 results. An earnings call follows at 6:30 PM IST that day.
Dr. Agarwals Health Care Merger & Restructuring Worth ₹711.2 Cr
Dr. Agarwals Health Care Limited has completed the merger of Dr. Agarwal's Eye Hospital Limited into itself for a total transaction value of ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care Limited allotted 18,200 equity shares upon the exercise of vested ESOPs. The transaction is valued at approximately ₹0.24 Crore.
- Value
- ₹0.24 Cr
Other management change announcements
All →Brahm Virat Industries Corporation Management Change
Brahm Virat Industries appointed Ranju Das as Non-Executive Non-Independent Director for 36 months, effective 5 November 2026, per its board outcome. The filing is a Management Change under the director appointment.
Hindustan Motors Management Change
Hindustan Motors re-appointed Mr. Prakash Sahu as Chief Executive Officer, effective 2026-11-05. The appointment runs until 2027-02-08.
- Execution
- 2026-11-05 to 2027-02-08
Panjon Management Change
Panjon's board approved unaudited standalone half-year results to September 2026 and noted Company Secretary Arpita Vijayargiya's resignation. The resignation takes effect 5 November 2026.
Khadim India Management Change
Khadim India disclosed the resignation of Abhijit Dan as Company Secretary and Compliance Officer, effective 21 November 2026, to pursue an alternate career. The filing is a KMP cessation with no monetary value.
Signatureglobal (India) Management Change
SIGNATUREGLOBAL re-appointed four executive directors, including the Managing Director, for 36 months from February 15, 2027. Leadership continuity is confirmed for the company's management team.
- Execution
- 36 months from 15-02-2027
Titan Company Management Change
Noel N. Tata retires as Vice-Chairman and non-executive director of Titan effective November 12, 2026, per Tata Group governance guidelines. Regulation 30 details filed in Annexure A.